The Effect of Temperature, pH, and Different Solubilizing Agents on Stability of Taxol Stability of taxol in solutions
Iranian Journal of Pharmaceutical Sciences,
Vol. 1 No. 1 (2005),
15 January 2005
,
Page 3-51
https://doi.org/10.22037/ijps.v1.39442
Abstract
Inabilities to attain adequate aqueous solubility and stability have made the preparation of a clinically suitable formulation of taxol difficult. Addition of nicotinamide (ND), 2-hydroxypropyl-b-cyclodextrin (HPßCD), polyethylene glycol, (PEG), bile salts (BS, 50:50 sodium cholate: deoxycholate), and cremophor
EL can improve the solubility of taxol. Studies were undertaken to compare the stability of taxol in HPßCD (20%), ND (20%), PEG (20%), BS (20%), and cremophor
EL (cremophor: ethanol 0.5% of each) solutions at 25, 37, 50, and 60 oC. Taxol concentration was measured by HPLC method. The rate of degradation
proceeded in a Log-linear fashion and increased progressively with the elevation of temperature in all solutions except in HPbCD which taxol had negligible degradation. In the absence of added agents, taxol exhibited the lowest and highest stability at pH 1.2 and 4.5, respectively. Taxol was most stable in HPbCD followed by PEG and then ND. The stability of taxol increased linearly with the HPbCD concentration (0-5% w/v). Due to the observed improved stability and solubility, HPbCD may be considered for pharmaceutical studies as a suitable stabilizer for formulation of taxol.
- Bile salts
- PEG
- Hydroxypropyl-b-cyclodextrin
- Inclusion complex
- HPLC
- Nicotinamide
- Taxol
- Stability
- Solubilizing agents
How to Cite
References
[2] Singla AK, Garg A, Aggrawal D. Paclitaxel and its formulations. Int J Pharm 2004; 235: 179- 192.
[3] Montaseri H. Taxol: Solubility, stability and bioavailability. PhD Thesis. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada. 1997.
[4] Koeller JM, Dorr RT. Pharmaceutical issues of paclitaxel. Ann Pharmacothe1994; 28: S5.
[5] Ringel I, Horwitz SB. Taxol is converted to 7- epitaxol, a biologically active isomer, in cell culture medium. J Pharmacol Exp Ther1987; 242: 692-698.
[6] Brown T, Haviin K, Weiss G, Canola J, Koeller J, Kuhn J. A phase I trial of taxol given by a 6-hour intravenous infusion. J Clin Oncol 1991; 9: 1261-1267.
[7] Zhou M, and Notari RE. Influence of pH, temperature, and buffers on the kinetic of ceftazidime degradation in aqueous solutions. J Pharm Sci 1995; 84: 534-538.
[8] Loftsson T, Baldvinsdottir J. Degradation of tauromustine (TCNU) in aqueous solutions. Acta Pharm Nord 1992; 4: 129-132.
[9] Connors K A. Chemical kinetics; VCH: New York, 1990; pp 17-58, 245-291.
[10] Yamamoto M, Hirayama F, Uekama K. Improvement of stability and dissolution of prostaglandin E1 by maltosyl-beta-cyclodextrin in lyophilized formulation. Chem Pharm Bull 1992; 40: 747-751.
[11] Vincieri FF, Mazzi G, Mulinacci N, Bambagiotti-Alberti M, Dall’ Acqua F, Vedaldi D. Improvement of dissolution characteristics of psoralen by cyclodextrins complexation. Farmaco 1995; 50: 543-547.
[12] Saleh SI, Rahman AA, Aboutaleb AE, Nakai Y, Ahmed MO. Effect of dimethyl-beta-cyclodextrin on nitrazepam stability. J Pharm Belg 1993; 48: 383-388.
[13] Bekers O, Beijnen JH, Tank MJ, Bult A, Underberg WJ. Effect of cyclodextrin on the chemical stability of mitomycins in alkaline solution. J Pharm Biomed Anal 1991; 9: 1055- 1060.
[14] Bekers O, Beijnen JH, Tank MJ, Burger DM, Meenhorst PL, Lombarts AJ, Underberg WJ. 2’,3’-Dideoxyinosine ddI: its chemical stability and cyclodextrin complexation in aqueous media. J Pharm Biomed Anal 1993; 11: 489-493.
[15] Loftsson T, Fridriksdottir H, Olafsdottir BJ. Solubilization and stabilization of drugs through cyclodextrin complexation. Acta Pharm Nord 1991; 3: 215-217.
[16] Hussain A, DiLuccio RC, Maurin MB. Complaxation of miricizine with nicotinamide and evaluation of the complexation constants by various methods. J Pharm Sci 1992; 82: 77-79.
[17] Rasool AA, Hussain AA, Dittert LW. Solubility enhancement of some water-insolubale drugs in the presence of nicotinamide and related compounds. J Pharm Sci .
- Abstract Viewed: 282 times
- IJPS_Volume 1_Issue 1_Pages 43-51 Downloaded: 321 times